SMARCA1 and cancer: Identification of cancer specific vulnerability arising from mutations in the context of the SWI/SNF chromatin remodeling complex has high clinical significance, because it paves the way to the development of more effective treatments combining radiotherapy with chromatin-targeted therapy options (23).